Clarendon Private’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75M Buy
66,191
+5,993
+10% +$240K 1.77% 13
2026
Q1
$2.18M Buy
60,198
+21,758
+57% +$834K 1.67% 15
2025
Q4
$1.48M Buy
38,440
+15,647
+69% +$588K 1.25% 18
2025
Q3
$825K Buy
+22,793
New +$796K 0.75% 36

Other funds holding QLTY

Clarendon Private's QLTY Position: Q2 2026 in Review

Clarendon Private increased its GMO US Quality ETF (QLTY) stake by 10% in Q2 2026, buying an estimated $240K and bringing the position to 66,191 shares worth $2.75M. The position accounts for 1.77% of the portfolio, ranked #13.

Clarendon Private first reported a position in QLTY in Q3 2025 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Clarendon Private held 66,191 shares of GMO US Quality ETF worth $2.75M as of Q2 2026.
  • Clarendon Private bought 5,993 GMO US Quality ETF shares in Q2 2026, an estimated $240K.
  • GMO US Quality ETF made up 1.77% of Clarendon Private's portfolio in Q2 2026, its #13 holding.
  • Clarendon Private first reported a position in GMO US Quality ETF in Q3 2025 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Clarendon Private's 13F filing for Q2 2026, filed 22 Jul 2026.